Navigation Links
VerteLoc™ Tops 500 Surgical Procedures, VGI Announces VerteLX™ and Seeks Potential Investors for Growth
Date:7/7/2009

l introduce a system that utilizes just a few small instruments for the lateral surgical approach and insertion of a unique biomechanically superior implant."

The VerteLX™ implant is like nothing ever seen previously in the spine market. VGI will demonstrate the VerteLX™ system at the North American Spine Society meeting in November with a limited product launch planned for Q2 2010. "VGI is entertaining the idea of a potential investor or partner to expand distribution to a broader market," Grayson continued. "We believe surgeon demand for the VerteLX™ product will be so great that we may require additional resources to allow for rapid expansion."

Company Profile

VG Innovations, Inc, (VGI) is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: www.verteloc.com


###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2603584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System
2. STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
3. STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
4. MMR Offers Free Surgical Masks to Call Attention to Importance of Personal Health Records in Preparing for Possible Swine Flu Pandemic
5. STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
6. STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
7. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
8. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
9. ATS Medical Announces Formation of Cryoablation Surgical Advisory Board
10. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
11. China Medicine to Distribute Dental and Surgical Instruments

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
VerteLoc™ Tops 500 Surgical Procedures, VGI Announces VerteLX™ and Seeks Potential Investors for Growth 
VerteLoc™ Tops 500 Surgical Procedures, VGI Announces VerteLX™ and Seeks Potential Investors for Growth
(Date:11/20/2009)...EGO, Nov. 20 Veridiam (www.veridia...d-size company category at the 2009 Workplace Exce... Diego Society for Human Resources Management and ...es practices. ,, Veridiam was one of nine winne... companies, honored at the recent awards ceremony....
(Date:11/20/2009)... METTLER TOLEDO recently announced that a ...timization Using At-Line Particle Characterization...n this webinar, the application of in situ particl...gn space and optimize a series of roller compactio...d roller compaction forces. , ...
(Date:11/19/2009)...LT, N.Y., Nov. 19 Dr. Mate Hidvegi... responds to a press release issued on November 17...pany for making false and self-serving statements ..., Dr. Hidvegi stated from his office in Budapes...arch on Avemar does not apply to AveULTRA, www.a...
(Date:11/19/2009)... MUNSTER, Germany, November 19 MON...on November 16th, 2009 Flibanserin in the,indicati...in Parkinson,s,disease for orphan drug status desi... Levodopa-induced dyskinesia is a complication of ... a serious burden to some of those,affected, since...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
..., N.J., April 4, 2008 Pharmasset,Inc. (Nasdaq: V...ms,Hepatitis C Conference being held on April 9, 2...er Price, Pharmasset,s Chief Executive Officer, wi...nd preclinical hepatitis C,virus (HCV) programs at... of Mr. Price,s overview via the,internet, log on ...
...nce Call Scheduled Friday, April 4, 2008 at 8:30 a...hts:, - 2007 pro forma consolidated net sales incr... $317.2 million, - Provided 2008 guidance: ... of $28 million to $30 million, -...3,800 at year-end 2007, - Established pharmacy o...
..., April 3, 2008 ADVENTRX,Pharmaceuticals, Inc. (A...ember of the Company,s Board of Directors, has joi...ly created position, and Chief Financial,Officer. ... with the,Company,s Chief Executive Officer and Pr..., help oversee internal execution of that strategy...
Other Biology Technology:Pharmasset to Present at the Canaccord Adams Hepatitis C Conference on Wednesday, April 9th 2Chem Rx Corporation Reports Full Year 2007 Financial Results 2Chem Rx Corporation Reports Full Year 2007 Financial Results 3Chem Rx Corporation Reports Full Year 2007 Financial Results 4Chem Rx Corporation Reports Full Year 2007 Financial Results 5Chem Rx Corporation Reports Full Year 2007 Financial Results 6Chem Rx Corporation Reports Full Year 2007 Financial Results 7Chem Rx Corporation Reports Full Year 2007 Financial Results 8Chem Rx Corporation Reports Full Year 2007 Financial Results 9Chem Rx Corporation Reports Full Year 2007 Financial Results 10Chem Rx Corporation Reports Full Year 2007 Financial Results 11Chem Rx Corporation Reports Full Year 2007 Financial Results 12Chem Rx Corporation Reports Full Year 2007 Financial Results 13Chem Rx Corporation Reports Full Year 2007 Financial Results 14Chem Rx Corporation Reports Full Year 2007 Financial Results 15ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 2ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 3ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer 4
(Date:11/19/2009)...han 2: The offspring of two inbred strains tend to...ing the gene-level variability that leads to this ...uld boost our ability to custom-tailor crops for s...uman consumption or high glucose content for bioma...A sequence of the common corn strain B73, Universi...
(Date:11/19/2009)...ewswire-FirstCall/ -- BIO-key International, Inc. ...ublic safety and finger-based biometric identifica...lder Meeting held today was adjourned without any ...t. ,, (Logo: http://www.newscom.com/cgi-bin/pr...99.3% of the 35 million votes cast voted in favor ...
(Date:11/19/2009)...son, T. Ming Chu Professor of Biochemistry and Mol...veling how regulatory proteins control the product.... Working with collaborators including Drs. Mitche... Philadelphia, they focused specifically on the co...ocytes). These cells contain large amounts of hemo...
Breaking Biology News(10 mins):U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5ReBuilder Medical Technologies Inc Announces Second Quarter 2009 Profits up 100 25 55535 1ReBuilder Medical Technologies Inc Announces Second Quarter 2009 Profits up 100 25 55535 2Caraco Pharmaceutical Laboratories Ltd Announces Reversal of Summary Judgment in Ultracet 28R 29 ANDA Patent Litigation 55531 1Caraco Pharmaceutical Laboratories Ltd Announces Reversal of Summary Judgment in Ultracet 28R 29 ANDA Patent Litigation 55531 2M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 1M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 2M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 3
...lution Named the Winner in the Best Security ...UNNYVALE, Calif., Sept. 3 Fujitsu Computer Produc...ive computer products including,hard disk drives, ...unced,today that its PalmSecure palm vein authenti...ecurity Solution for Healthcare Category as part o...
...niversity of Texas Medical Branch at Galveston res... the process by which the Ebola Zaire virus infect... the deadly disease produced by the virus. , Ebol...r in its victims and inflicts mortality rates clos...ntiviral therapy has been developed against the vi...
...ped lists of places with the worst air pollution i...ve improved the situation, tiny particles called a...tists from UC San Diego and six other institutions...city to precisely identify aerosols that make up t... mix. , This forensic work will help to identify ...
Other Biology News:Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 2Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 3Scientists uncover Ebola cell-invasion strategy 2Smoke smudges Mexico City's air, chemists identify sources 2Smoke smudges Mexico City's air, chemists identify sources 3
Hoagland's No. 2 Basal Salt Mixture from Sigma-Aldrich
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
...00 Q TRAP(TM) LC/MS/MS System, a high performance ...trometer for the drug discovery, drug development ...ap (LIT) Technology from the leaders in mass spect...e analysis with the proven, high sensitivity quant...
Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich
Biology Products: